Southern Nevada Officials Clarify COVID Changes Post-Public Health Emergency

Just one year ago, the COVID-19 omicron variant was spreading in communities across the United States. That meant increased hospitalizations and deaths, which is why public health officials recommended updated vaccinations along with masking, social distancing and the other pandemic steps we’ve been taking since 2020. Although the federal COVID-19 public health emergency officially ended ...

Read More

FDA Chief’s Unwelcome Message To Biotech Execs: ‘Prices Of Drugs Are Too High’

The Food and Drug Administration’s top official Wednesday told a Boston gathering of biopharma industry leaders something few of them wanted to hear: Americans are paying too much for prescription medicines. ”The prices of drugs are too high in the US, and we have to come to grips with it,” FDA Commissioner Robert Califf told ...

Read More

Retail Pharmacies Push To Save Role — And Payments — As Providers

Pharmacies that carved out new lines of business during the pandemic are pushing to expand their reach amid a broader effort to rethink the health care consumer experience. Why it matters: Pharmacies got paid to deliver vaccines, tests, and treatments for COVID during the pandemic. The experience primed consumers to expect the kind of on-demand health access ...

Read More

To Fill Offices, Google Issues Ultimatum While Salesforce Tries Charity

The executives of corporate America are stepping up efforts to get workers back into the office, using a combination of threats and incentives to get employees to give up the work-from-home lifestyle they adopted in the first years of the covid-19 pandemic. For over a year, Google has asked workers to come in three days a ...

Read More

Cancer Centers Say US Chemotherapy Shortage Is Leading To Treatment Complications

A growing shortage of common cancer treatments is forcing doctors to switch medications and delaying some care, prominent U.S. cancer centers say. The National Comprehensive Cancer Network said Wednesday that nearly all the centers it surveyed late last month were dealing with shortages of carboplatin and cisplatin, a pair of drugs used to treat a range of ...

Read More

Once Cushioned From Lawmaker Scrutiny, Hospitals See A Shift

The arguments that hospitals’ trade groups have used for years — mainly, that they need more money from the government — are beginning to fall flat, indicating one of Washington’s most powerful lobbying juggernauts may be losing some goodwill. While groups like the American Hospital Association, which represents about 5,000 hospitals and which spent $27 ...

Read More

The Debt Ceiling Deal Takes a Bite Out of Health Programs. It Could Have Been Much Worse.

Policy analysts, Democrats, and Republicans dissatisfied with the deal agree: Federal health programs have dodged a budgetary bullet in the Washington showdown over raising the nation’s debt ceiling.

Read More

Employers Hope To Weather Inflation Without Shifting Healthcare Costs To Workers: Survey

Employers are bracing for 2024, fearing they’ll face inflation and soaring healthcare costs while still trying to recruit and retain workers in a tight labor market, a new survey shows.

Read More

Appeals Court To Hear Arguments About Obamacare Preventive Coverage

A federal appeals court will hear arguments Tuesday about whether to continue a pause of a Texas district court’s ruling that struck down an ObamaCare provision requiring insurers to cover preventive services for free.

Read More

FDA allows temporary import of unapproved Chinese cancer drug to ease U.S. shortage

The U.S. Food and Drug Administration has authorized the temporary importation of an unapproved chemotherapy drug from China in effort to ease an acute shortage of cancer drugs in the United States, according to an update posted to the agency’s website Friday.

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square